세계의 비강 로션 스프레이 시장 : 제품 유형별, 용도별, 연령층별, 유통 채널별, 지역별
Nasal Lotion Spray Market, By Product Type, By Application, By Age Group (Adults, Children, and Infants), By Distribution Channel, By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
상품코드
:
1741209
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 비강 로션 스프레이 시장은 2025년 122억 9,000만 달러로 추정되고, 2032년까지 194억 8,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 6.8%의 복합 연간 성장률(CAGR)로 성장할 것으로 예측됩니다.
| 보고 범위 |
보고서 세부정보 |
| 기준연도 |
2024년 |
2025년 시장 규모 |
122억 9,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측기간 2025-2032년 CAGR: |
6.80% |
2032년 가치 예측 |
194억 8,000만 달러 |
세계의 비강 로션 스프레이 시장은 호흡기 질환과 알레르기의 유병률 상승으로 최근 몇 년 동안 크게 성장하고 있습니다. 비강 로션 스프레이는 비강에 국소적으로 직접 작용하기 때문에 경구약보다 점점 채용되고 있습니다.
시장 역학:
비강 로션 스프레이 세계 시장은 코 막힘, 알레르기 및 기타 코 질환의 이환율 증가로 인한 것입니다. 비강 로션 스프레이는 신속한 완화와 국소적인 작용에 의해 코 증상의 치료에 널리 사용되고 있습니다. 비강 로션 스프레이가 더 좋다는 인식이 낮기 때문에 시장 개척을 방해할 수 있습니다.
비강 질환 유병률 증가, 노인 인구 증가, 비강 로션 스프레이 수요 증가, 사람들 의식 증가, 신제품 도입은 예측 기간 동안 비강 로션 스프레이 시장 성장을 가속할 것으로 예상되는 주요 요인입니다.
시장 개척 기업은 신규 개발 제품의 승인 취득에 여념이 없으며, 이것이 예측 기간 중의 비강 로션 스프레이 세계 시장의 성장을 가속할 것으로 예측됩니다. 2021년 Cipla Limited는 미국 식품의약국(FDA)으로부터 수마트립탄 점비 스프레이 20mg의 간략 신약 승인 신청(ANDA)의 최종 승인을 취득했다고 발표했습니다. Cipla의 Sumatriptan 비강 스프레이 USP 20mg은 흑소 GlaxoSmithKline의 Imitrex 비강 스프레이의 AB 랭크의 제네릭 의약품입니다.
그러나 낮은 인지도와 입수가 어려움은 예측 기간 동안 비강 로션 스프레이 세계 시장 성장을 방해할 것으로 예측됩니다.
이 조사의 주요 특징
- 본 보고서는 세계의 비강 로션 스프레이 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모 및 복합연간 성장률(CAGR)을 제공합니다.
- 또, 다른 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스를 해설했습니다.
- 또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 업적, 전략 등의 다음 파라미터를 바탕으로 세계의 비강 로션 스프레이 시장에서 주요 기업 프로파일을 제공합니다.
- 이 보고서로부터의 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
- 세계의 비강 로션 스프레이 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자에 대응하고 있습니다.
- 이해관계자는 세계의 비강 로션 스프레이 시장의 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 주요 하이라이트
- 규제 시나리오
- 최근 동향
- 제품 출시/승인
- PEST 분석
- PORTER 분석
- 합병, 인수 및 제휴
제4장 세계의 비강 로션 스프레이 시장 - 코로나 바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 세계의 비강 로션 스프레이 시장 : 제품 유형별, 2020-2032년
- 생리 식염수
- 스테로이드 비강 스프레이
- 항히스타민 비강 스프레이
- 코 막힘 해소 스프레이
- 천연 및 오가닉 비강 스프레이
- 기타(옥시메타졸린, 페닐레프린 등)
제6장 세계의 비강 로션 스프레이 시장 : 용도별, 2020-2032년
- 알레르기 완화
- 부비강염 치료
- 감기 및 인플루엔자 완화
- 화분증 완화
- 기타(코의 건조나 가려움의 완화 등)
제7장 세계의 비강 로션 스프레이 시장 : 연령층별, 2020-2032년
제8장 세계의 비강 로션 스프레이 시장 : 유통 채널별, 2020-2032년
- 병원 약국
- 소매 약국
- 전자상거래
- 기타(하이퍼마켓, 편의점 등)
제9장 세계의 비강 로션 스프레이 시장 : 지역별, 2020-2032년
- 북미
- 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동 및 아프리카
- GCC
- 이스라엘
- 남아프리카
- 북아프리카
- 중앙 아프리카
- 기타 중동
제10장 경쟁 구도
- 기업 프로파일
- GlaxoSmithKline plc
- Johnson & Johnson
- Pfizer Inc.
- Novartis AG
- AstraZeneca PLC
- Sanofi SA
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Perrigo Company plc
- Prestige Consumer Healthcare Inc
- NeilMed Pharmaceuticals, Inc
- Church & Dwight Co., Inc
- Navage, Inc.
- Xlear, Inc.
제11장 섹션
JHS
영문 목차
Nasal Lotion Spray Market is estimated to be valued at USD 12.29 Bn in 2025 and is expected to reach USD 19.48 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 12.29 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
6.80% |
2032 Value Projection: |
USD 19.48 Bn |
Global nasal lotion spray market has been growing significantly over the past few years due to rising prevalence of respiratory diseases and allergies. Nasal lotion sprays provide quick relief from congestion and allow easy breathing by thinning the mucus in nasal passageways. They contain saline solutions or other medications that help loosen mucus and ease respiration. Nasal lotion sprays are increasingly being adopted over oral medications owing to their localized and direct effect on nasal cavities. Furthermore, innovations in delivery mechanisms have made nasal sprays more convenient to use.
Market Dynamics:
The global nasal lotion spray market is driven by rising incidence of nasal congestion, allergies, and other nasal disorders. Growing pollution levels, changing climate conditions, and sedentary lifestyles have contributed to increased nasal problems. Nasal lotion sprays are widely used for treating nasal symptoms owing to quick relief and localized action. However, low awareness about benefits of nasal lotion sprays over traditional nasal sprays in developing regions may hinder market growth. Moreover, availability of alternative treatment options poses a challenge. Nonetheless, ongoing R&D to enhance efficacy and duration of treatment presents high opportunity for market expansion. Key players are investing in new product launches with advanced formulations to capitalize on existing opportunities.
Increasing prevalence of nasal disorders, growing geriatric (aging) population, increasing demand for nasal lotion sprays, growing awareness among people, and introduction of novel products are major factors expected to drive growth of the global nasal lotion spray market during the forecast period.
Market players are indulged in receiving approval for their new developed product and this is expected to drive the growth of the global nasal lotion spray market, over the forecast period. In 2021, Cipla Limited, a pharmaceutical company, announced that it received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the U.S. Food and Drug Administration (U.S. FDA). Cipla's Sumatriptan Nasal Spray USP, 20 mg is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray.
However, lack of awareness and limited availability is expected to hamper the growth of the global nasal lotion spray market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global nasal lotion spray market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global nasal lotion spray market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Perrigo Company plc, Prestige Consumer Healthcare Inc., NeilMed Pharmaceuticals, Inc., Church & Dwight Co., Inc., Navage, Inc. and Xlear, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global nasal lotion spray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal lotion spray market
Detailed Segmentation:
- By Product Type:
- Saline Solution
- Steroid Nasal Sprays
- Antihistamine Nasal Sprays
- Decongestant Nasal Sprays
- Natural/Organic Nasal Sprays
- Others (Oxymetazoline, Phenylephrine and Others)
- By Application:
- Allergy Relief
- Sinusitis Treatment
- Cold & Flu Relief
- Hay Fever Relief
- Others (Nasal dryness & itch relief and Others)
- By Age Group:
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
- Others (Hypermarkets, Convenience Stores, among others)
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- GlaxoSmithKline plc.
- Johnson & Johnson
- Pfizer Inc.
- Novartis AG
- AstraZeneca PLC
- Sanofi S.A.
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Perrigo Company plc.
- Prestige Consumer Healthcare Inc.
- NeilMed Pharmaceuticals, Inc.
- Church & Dwight Co., Inc.
- Navage, Inc.
- Xlear, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Age Group
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Nasal Lotion Spray Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Nasal Lotion Spray Market, By Product Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Saline Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Steroid Nasal Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Antihistamine Nasal Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Decongestant Nasal Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Natural/Organic Nasal Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others (Oxymetazoline, Phenylephrine and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Nasal Lotion Spray Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Allergy Relief
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Sinusitis Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Cold & Flu Relief
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Hay Fever Relief
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others (Nasal dryness & itch relief and Others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Nasal Lotion Spray Market, By Age Group, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Children
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Infants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Global Nasal Lotion Spray Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- E-commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others (Hypermarkets, Convenience Stores, among others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Global Nasal Lotion Spray Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Sub-region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Sub-region, 2021 - 2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Bn)
- GCC
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of Middle East
10. Competitive Landscape
- Company Profile
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Prestige Consumer Healthcare Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NeilMed Pharmaceuticals, Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
11. Section
- References
- Research Methodology
- About us
관련자료
